Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Anne-Laure Dubessy"'
Autor:
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, Maria Pia Amato, Tobias Derfuss, Franziska Di Pauli, Ellen Iacobaeus, Marcin Mycko, Hesham Abboud, Anat Achiron, Angelo Bellinvia, Alexey Boyko, Jean-Laurent Casanova, David Clifford, Ruth Dobson, Mauricio F Farez, Massimo Filippi, Kathryn C Fitzgerald, Mattia Fonderico, Riadh Gouider, Yael Hacohen, Kerstin Hellwig, Bernhard Hemmer, Ludwig Kappos, Filipa Ladeira, Christine Lebrun-Frénay, Céline Louapre, Melinda Magyari, Matthias Mehling, Celia Oreja-Guevara, Lekha Pandit, Caroline Papeix, Fredrik Piehl, Emilio Portaccio, Isabel Ruiz-Camps, Krzysztof Selmaj, Steve Simpson-Yap, Aksel Siva, Per Soelberg Sorensen, Maria Pia Sormani, Maria Trojano, Adi Vaknin-Dembinsky, Sandra Vukusic, Brian Weinshenker, Heinz Wiendl, Alexander Winkelmann, María Isabel Zuluaga Rodas, Mar Tintoré, Bruno Stankoff
Publikováno v:
Multiple Sclerosis Journal. 28:1424-1456
Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease-modifying treatments (DMTs) are now available. However, most DMTs are associated
Autor:
Sandra Vukusic, Romain Marignier, Jonathan Ciron, Bertrand Bourre, Mikael Cohen, Romain Deschamps, Maxime Guillaume, Laurent Kremer, Julie Pique, Clarisse Carra-Dalliere, Laure Michel, Emmanuelle Leray, Anne-Marie Guennoc, David Laplaud, Géraldine Androdias, Caroline Bensa, Kevin Bigaut, Damien Biotti, Pierre Branger, Olivier Casez, Elodie Daval, Cécile Donze, Anne-Laure Dubessy, Cécile Dulau, Françoise Durand-Dubief, Benjamin Hebant, Arnaud Kwiatkowski, Julien Lannoy, Adil Maarouf, Eric Manchon, Guillaume Mathey, Xavier Moisset, Alexis Montcuquet, Thomas Roux, Elisabeth Maillart, Christine Lebrun-Frenay
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2023, 29 (1), pp.37-51. ⟨10.1177/13524585221130934⟩
Multiple Sclerosis Journal, 2023, 29 (1), pp.37-51. ⟨10.1177/13524585221130934⟩
Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series of commonalities with MS, but also s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::909d2f63c4c6a1204c4f51dee65f4292
https://hal.ehesp.fr/hal-03871563
https://hal.ehesp.fr/hal-03871563
Autor:
Sandra Vukusic, Clarisse Carra-Dalliere, Jonathan Ciron, Elisabeth Maillart, Laure Michel, Emmanuelle Leray, Anne-Marie Guennoc, Bertrand Bourre, David Laplaud, Géraldine Androdias, Caroline Bensa, Kevin Bigaut, Damien Biotti, Pierre Branger, Olivier Casez, Mikael Cohen, Elodie Daval, Romain Deschamps, Cécile Donze, Anne-Laure Dubessy, Cécile Dulau, Françoise Durand-Dubief, Maxime Guillaume, Benjamin Hebant, Laurent Kremer, Arnaud Kwiatkowski, Julien Lannoy, Adil Maarouf, Eric Manchon, Guillaume Mathey, Xavier Moisset, Alexis Montcuquet, Julie Pique, Thomas Roux, Romain Marignier, Christine Lebrun-Frenay
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2023, 29 (1), pp.11-36. ⟨10.1177/13524585221129472⟩
Multiple Sclerosis Journal, 2023, 29 (1), pp.11-36. ⟨10.1177/13524585221129472⟩
Objective: The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS). Background: MS typically affects young women in their childbearing years. Increasing evidence is av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20fac9ac5a609ad94036fe950af2cf4
https://hal-univ-rennes1.archives-ouvertes.fr/hal-03882738
https://hal-univ-rennes1.archives-ouvertes.fr/hal-03882738
Autor:
Céline, Louapre, Michella, Ibrahim, Elisabeth, Maillart, Basma, Abdi, Caroline, Papeix, Bruno, Stankoff, Anne-Laure, Dubessy, Caroline, Bensa-Koscher, Alain, Créange, Zina, Chamekh, Catherine, Lubetzki, Anne-Geneviève, Marcelin, Jean-Christophe, Corvol, Valérie, Pourcher, Sylvie, Forlani
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group, 2021, jnnp-2021-326904. ⟨10.1136/jnnp-2021-326904⟩
Journal of Neurology, Neurosurgery, and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 2021, jnnp-2021-326904. ⟨10.1136/jnnp-2021-326904⟩
Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group, 2021, jnnp-2021-326904. ⟨10.1136/jnnp-2021-326904⟩
Journal of Neurology, Neurosurgery, and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 2021, jnnp-2021-326904. ⟨10.1136/jnnp-2021-326904⟩
BackgroundSARS-CoV-2 seroconversion rate after COVID-19 may be influenced by disease-modifying therapies (DMTs) in patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorders (NMO-SD).ObjectiveTo investigate the seroprevalence an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecdf5b2bf3e4203883ac8f3dc17b13ab
https://hal.sorbonne-universite.fr/hal-03471111
https://hal.sorbonne-universite.fr/hal-03471111
Autor:
Catherine Goujon, C. Papeix, Catherine Lubetzki, Christine Lebrun-Frenay, Bruno Stankoff, Jean-Sébastien Vidal, Elisabeth Maillart, C. Bensa, Julie Mazoyer, Odile Launay, Valérie Pourcher, Serge Mrejen, Céline Louapre, Anne-Laure Dubessy, Michel Rosenheim
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 27(14)
Background: Yellow fever vaccine (YFV) is not advised for multiple sclerosis (MS) patients because of the potential risk of post-vaccine relapses. Objective: To assess the risk of relapsing-remitting multiple sclerosis (RR-MS) worsening after YFV. Me
Autor:
Yassine Taoufik, Anne Laure Dubessy, Houria Hendel-Chavez, Bruno Stankoff, Marie-Ghislaine De-Goer, Jeanne Garcia, Anne Sophie L'Honneur
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 27(4)
Background: Progressive multifocal leukoencephalopathy (PML) among multiple sclerosis (MS) patients receiving dimethyl fumarate (DMF) is associated with iatrogenic lymphopenia, predominating on CD8+ T-cells. Objectives and Methods: We report an unusu
Autor:
Bruno Stankoff, Michel Tiberge, Rana Assouad, Michel Clanet, Isabelle Arnulf, Catherine Lubetzki, Sophie Tezenas du Montcel, Caroline Papeix, Frédérique Viala, Anne-Laure Dubessy
Publikováno v:
Neurology. 97(1)
ObjectiveTo evaluate sleepiness and central hypersomnia in multiple sclerosis (MS)–associated fatigue, we performed long-term polysomnography in patients with MS and healthy controls.MethodsPatients with MS and healthy controls completed questionna
Autor:
François-Xavier Lejeune, Anne-Laure Dubessy, Quentin Rappeneau, Sean A. Freeman, Julien Tailleur, Catherine Lubetzki, Nathalie Sol-Foulon, Anne Desmazières, Marie-Stéphane Aigrot, Melina Thetiot, Thomas Roux
Publikováno v:
Glia
Glia, Wiley, 2020, 68 (9), pp.1891-1909. ⟨10.1002/glia.23812⟩
Glia, 2020, 68 (9), pp.1891-1909. ⟨10.1002/glia.23812⟩
Glia, Wiley, 2020, 68 (9), pp.1891-1909. ⟨10.1002/glia.23812⟩
Glia, 2020, 68 (9), pp.1891-1909. ⟨10.1002/glia.23812⟩
SUMMARYIn vertebrates, fast saltatory conduction along myelinated axons relies on the node of Ranvier. How nodes assemble on CNS neurons is not yet fully understood. We recently highlighted that clusters similar to nodes can form prior to myelin depo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfefac9c63aee50bbcfe0dca6b528b8c
Autor:
Jean-Baptiste Maranci, Smaranda Leu-Semenescu, Valérie Attali, Isabelle Arnulf, Anne-Laure Dubessy
Publikováno v:
SLEEP
SLEEP, 2017, 40 (2), ⟨10.1093/sleep/zsw043⟩
SLEEP, 2017, 40 (2), ⟨10.1093/sleep/zsw043⟩
Introduction To describe patients with sexsomnia and to contrast their clinical and sleep measures with those of healthy controls and sleepwalkers. Aims and methods Subjects referred for sexsomnia and for sleepwalking/night terror were interviewed, c
Publikováno v:
Revue Neurologique. 170:770-778
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS), characterized by CNS-restricted inflammation with subsequent demyelination and neurodegeneration. Current disease-modifying therapies efficiently reduce relapse rate an